TherapeuticsMD Announces Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
TherapeuticsMD (TXMD) Misses Q3 EPS by 2c
November 3, 2016 4:31 PM EDTTherapeuticsMD (NYSE: TXMD) reported Q3 EPS of ($0.13), $0.02 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $5.53 million versus the consensus estimate of $5.76 million.
We are making excellent progress this year advancing our pipeline and enhancing our commercial capabilities... More
